Kratom Reports Rose Amid Regulatory Shifts in 2026
Poison center reports spiked in the first half of 2026, prompting new state-level restrictions.
Updated on Oct. 7, 2026 in Substance Abuse
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?
Poison centers across the United States logged 3,190 kratom-related reports during the first half of 2026, a surge indicating a projected 68% increase in annual volume compared to 2025. This rise has triggered a patchwork of state-level regulations ranging from total bans to specific potency limits.
Why it matters
The increase in reports follows the widespread availability of concentrated kratom products, which pose heightened risks of dependence and withdrawal. Understanding these trends is critical for those managing health and weighing the risks of using unregulated substances.
Poison centers recorded 3,190 kratom-related reports in the first half of 2026, following a decade-long increase that saw annual reports grow from 258 in 2015 to 3,434 in 2025. These figures track alongside 233 kratom-associated deaths reported between 2015 and 2025.
The players
Drug Enforcement Administration (DEA)
The federal agency responsible for enforcing controlled substances laws that recently scheduled synthetic kratom alkaloids.
The details
Many modern kratom products contain concentrated 7-hydroxymitragynine (7-OH), which acts on the body's mu-opioid receptors similarly to morphine and fentanyl. While natural kratom plants have lower levels of alkaloids, these engineered concentrations significantly amplify the potential for dependence and withdrawal symptoms. Regulatory responses vary, with some states imposing potency caps or age requirements, while others have moved to classify kratom or specific synthetic alkaloids as Schedule I substances.
Timeline
2015-2025: 233 kratom-associated deaths were recorded.
First half of 2026: Poison centers logged 3,190 kratom reports.
July 2026: A Tennessee ban on kratom took effect.
August 2026: Massachusetts issued an emergency kratom restriction.
August 26, 2026: The DEA scheduled synthetic kratom compounds in Schedule I.
Health Landscape
Regulatory action on kratom is increasingly mirroring the framework of the Controlled Substances Act, as states move to categorize specific alkaloids and products. This shift follows the emergence of concentrated synthetic compounds that mark a departure from traditional, leaf-based consumption.
Because kratom products vary significantly in potency and regulation, discuss the use of any herbal supplements with your physician to understand potential interactions or health risks. Be aware that many products are currently unregulated, and those experiencing symptoms should consult a healthcare provider.
The takeaway
The rise in poison center reports highlights the risks associated with highly concentrated kratom extracts. If you use or are considering using these products, speak with your doctor about potential interactions and the safety profile of specific formulations.
Further reading
Learn more about the evolving risks and policies surrounding Substance Abuse trends.
Source note: This article includes information reported by Medical Daily.
Live Poll
Should states ban all kratom sales instead of allowing a regulated market for adults?
